Update: Diasome Presents OPTI-2 Phase 2b Data at the ADA 86th Scientific Sessions
Demonstrates HDV™-Insulin Lispro Maintains Glycemic Control While Reducing Hypoglycemia in Adults with Type 1 Diabetes
Latest Updates

Single-Blind, Placebo-Controlled, Dose-Ranging Trial of Oral HDV-Insulin in Patients With Type 2 Diabetes Mellitus

Latest Updates

News

WKYC: "A smarter insulin, better meal timing and the avocado test"

Read More

CareTalk Podcast: "Targeting the Root Causes of Metabolic Disease w/ Bob Geho, Founder & CEO, Diasome”

Read More

Medscape Covers Diasome's OPTI-2 Liver-Directed Insulin Data from ADA 2026

Read More

OPTI-2 Trial Results Presented at ADA on June 7th at 5pm EST

Read More
View All